auryx raised $2M in a pre-seed round announced on April 30, 2026. auryx is on a mission to create the world’s best foundation model for turning sound into health insights.
auryx is on a mission to create the world’s best foundation model for turning sound into health insights.
auryx, based in London, United Kingdom, announced $2M in pre-seed financing on April 30, 2026.
Participants include PurposeTech, Cambridge Enterprise Ventures, Vento, Celero Ventures, EWOR.
A biotechnology company developing small molecule drugs that target RNA modifying enzymes for the treatment of cancer.
Hypervision Surgical develops computer-assisted tissue analysis tools for surgeons.
mbiomics develops microbiome analysis technology to inform targeted therapies.